Researchers conducting studies with the TSC Preclinical Consortium have published several articles in well-regarded, peer-reviewed biomedical journals, including:
- Shrestha, S., et al. Angiotensin II receptor type 1 blockade regulates Klotho expression to induce TSC2-deficient cell death. doi.org/10.1016/j.jbc.2022.102580
- Agarwal S., et al. Defining the Magnetic Resonance Features of Renal Lesions and Their Response to Everolimus in a Transgenic Mouse Model of Tuberous Sclerosis Complex. doi.org/10.3389/fonc.2022.851192
- Nguyen, LH., et al. Inhibition of MEK-ERK signaling reduces seizures in two mouse models of tuberous sclerosis complex. doi.org/10.1016/j.eplepsyres.2022.106890
- Vaughan, RM., et al. Chemical Biology Screening Identifies a Vulnerability to Checkpoint Kinase Inhibitors in TSC2-Deficient Renal Angiomyolipomas. doi.org/10.3389/fonc.2022.852859